GlassScriptPhysician profile
Sherwin Zargaroff
NPI 1578715983
$4,566.36
in general payments reported to CMS, 2019-2025
20 companies · $1,105 in 2025
The $1,105 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $139 · 2022: $203 · 2023: $2,132 · 2024: $987 · 2025: $1,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,239 · Travel and Lodging: $985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,239.19 |
| Travel and Lodging | $985.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,871.51 | 2022-2025 | Urolift, Barrigel |
| Palette Life Sciences, INC. | $1,362.33 | 2023 | |
| Axonics, INC. | $306.67 | 2023-2024 | Bulkamid, Axonics |
| Boston Scientific Corporation | $223.68 | 2020-2024 | Rezum Generator |
| Endo USA, INC. | $125.15 | 2024-2025 | Xiaflex, Aveed |
| Myovant Sciences INC. | $118.13 | 2022 | |
| Ferring Pharmaceuticals INC. | $109.89 | 2024-2025 | Adstiladrin |
| Endo Pharmaceuticals INC. | $74.14 | 2022-2024 | Aveed, Xiaflex |
| Coloplast Corp | $65.63 | 2020-2025 | |
| Urogen Pharma, INC. | $62.06 | 2025 | |
| Myriad Genetic Laboratories, INC. | $47.58 | 2025 | Myrisk |
| Sumitomo Pharma America, INC. | $44.38 | 2023 | Orgovyx |
| Idorsia Pharmaceuticals US INC | $35.00 | 2023 | Quviviq |
| Verity Pharmaceuticals INC. | $21.59 | 2024 | Trelstar |
| Tolmar, INC. | $18.92 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $18.07 | 2024 | Inspire |
| Abbvie INC. | $17.38 | 2025 | |
| Progenics Pharmaceuticals, INC. | $17.07 | 2024 | |
| Neotract INC. | $14.26 | 2020 | |
| Olympus America INC. | $12.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherwin Zargaroff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.